GSK plc

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Net Income $15.0b $4.9b $2.6b $5.7b
Net Income From Continuing Operations $4.9b $5.3b $3.0b $6.3b
Other Adjustments To Reconcile Profit Loss ($21.0m) ($95.0m) ($62.0m) ($61.0m) ($27.0m) ($129.0m) ($170.0m) ($100.0m) ($110.0m) ($9.0m)
Amortization Cash Flow $1.1b $1.2b $1.5b $1.3b
Depreciation $1.1b $1.1b $1.1b $1.1b
Deferred Tax $707.0m $756.0m $526.0m $1.1b
Adjustments For Share-Based Payments $319.0m $333.0m $360.0m $365.0m $381.0m $367.0m $346.0m $307.0m $344.0m $374.0m
Adjustments For Income Tax Expense $877.0m $1.4b $754.0m $953.0m $580.0m $346.0m $707.0m $756.0m $526.0m $1.1b
Additional Financial Items
Adjustments For Current Tax Of Prior Period ($149.0m) ($508.0m) ($492.0m) ($420.0m) $66.0m $172.0m ($60.0m) $43.0m ($92.0m) ($49.0m)
Adjustments For Decrease Increase In Trade Account Receivable ($188.0m) ($287.0m) ($429.0m) ($32.0m) ($224.0m) ($782.0m) ($158.0m) ($794.0m) $298.0m ($613.0m)
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates ($94.0m) $3.0m ($36.0m) $0 $1.0m $6.0m $0
Adjustments For Increase Decrease In Trade Account Payable $96.0m $11.0m $131.0m $263.0m $225.0m $284.0m $494.0m ($15.0m) ($179.0m) $131.0m
Goodwill $6.0b $5.7b $5.8b $10.6b $10.6b $10.6b $7.0b $6.8b $7.0b $7.0b
Payments Of Lease Liabilities Classified As Financing Activities $214.0m $227.0m $215.0m $202.0m $197.0m $226.0m $241.0m
Payments To Acquire Or Redeem Entitys Shares $1.4b
Proceeds From Issuing Shares $89.0m $56.0m $74.0m $51.0m $29.0m $21.0m $25.0m $10.0m $20.0m $15.0m
Purchase Of Intangible Assets Classified As Investing Activities $809.0m $657.0m $452.0m $898.0m $1.0b $1.8b $1.1b $1.0b $1.6b $1.6b
Beginning Cash Position $3.8b $3.4b $2.9b $3.4b
Change In Inventory ($269.0m) ($424.0m) ($294.0m) ($140.0m)
Change In Other Current Assets ($962.0m) ($457.0m) $999.0m ($1.1b)
Change In Other Current Liabilities $1.6b $492.0m $1.8b $465.0m
Change In Payable $489.0m $674.0m ($789.0m) $474.0m
Change In Receivables ($616.0m) ($649.0m) $340.0m ($1.1b)
Change In Working Capital $270.0m ($364.0m) $2.1b ($1.4b)
Changes In Cash ($546.0m) ($468.0m) $599.0m ($177.0m)
End Cash Position $3.4b $2.9b $3.4b $3.2b
Financing Cash Flow $823.0m ($5.6b) ($4.7b) ($3.7b)
Free Cash Flow $5.1b $4.4b $3.6b $4.8b
Gain Loss On Investment Securities ($8.0m) ($1.0m) ($10.0m) ($4.0m)
Gain Loss On Sale Of Business ($36.0m) ($1.0m) $5.0m $9.0m
Gain Loss On Sale Of PPE ($185.0m) ($12.0m) ($170.0m) ($49.0m)
Interest Received CFI $64.0m $115.0m $138.0m $154.0m
Investing Cash Flow ($8.8b) ($1.6b) ($1.2b) ($4.2b)
Issuance Of Capital Stock $25.0m $10.0m $20.0m $15.0m
Net Business Purchase And Sale ($3.1b) $291.0m $1.4b ($1.6b)
Net Intangibles Purchase And Sale ($919.0m) ($1.0b) ($1.5b) ($1.5b)
Net PPE Purchase And Sale ($997.0m) ($1.3b) ($1.3b) ($1.3b)
Other Non Cash Items $350.0m $470.0m $398.0m $568.0m
Purchase Of Business ($3.4b) ($1.6b) ($988.0m) ($1.8b)
Purchase Of Intangibles ($1.1b) ($1.0b) ($1.6b) ($1.6b)
Purchase Of PPE $1.5b $1.3b $1.3b $1.2b $1.2b ($1.1b) ($1.3b) ($1.4b) ($1.3b)
Repurchase Of Capital Stock $0 $0 ($1.4b)
Sale Of Business $238.0m $1.9b $2.4b $189.0m
Sale Of Intangibles $196.0m $12.0m $131.0m $115.0m
Sale Of PPE $146.0m $28.0m $65.0m $24.0m
Stock Based Compensation $346.0m $307.0m $344.0m $374.0m
Profit or Loss $1.1b $2.2b $4.0b $5.3b $6.4b $5.1b $15.6b $5.3b $3.0b $6.3b
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities $98.0m $281.0m $168.0m $95.0m $68.0m $143.0m $146.0m $28.0m $65.0m $24.0m
Capital Expenditure ($2.3b) ($2.3b) ($3.0b) ($3.0b)
Net Investment Purchase And Sale $1.0m $72.0m $21.0m $11.0m
Sale Of Investment $18.0m $1.0m $72.0m $21.0m
Net Other Investing Changes ($122.0m) ($3.8b) ($1.0m)
Cash flows from financing activities:
Issuance Of Debt $2.0b $223.0m $1.3b $3.2b
Long Term Debt Issuance $1.0b $223.0m $1.1b $2.0b
Net Issuance Payments Of Debt ($4.6b) ($2.4b) ($1.2b) $1.5b
Net Long Term Debt Issuance ($5.6b) ($2.0b) ($540.0m) $579.0m
Net Short Term Debt Issuance $1.0b ($333.0m) ($626.0m) $927.0m
Short Term Debt Issuance $1.0b $0 $266.0m $1.2b
Long Term Debt Payments ($6.7b) ($2.3b) ($1.6b) ($1.4b)
Repayment Of Debt ($6.7b) ($2.6b) ($2.5b) ($1.7b)
Short Term Debt Payments $0 ($333.0m) ($892.0m) ($288.0m)
Common Stock Issuance $25.0m $10.0m $20.0m $15.0m
Net Common Stock Issuance $25.0m $10.0m $20.0m ($1.4b)
Common Stock Payments $0 $0 ($1.4b)
Dividends paid $5k $4k $4k $4k $4k $4k $3k $2k $2k $3k
Dividends Paid Ordinary Shares Per Share $0.80 $0.80 $0.80 $80.00 $80.00 $80.00 $0.61 $0.58 $0.61 $0.66
Cash Dividends Paid ($3.5b) ($2.2b) ($2.4b) ($2.6b)
Common Stock Dividend Paid ($3.5b) ($2.2b) ($2.4b) ($2.6b)
Dividends Received CFI $6.0m $231.0m $31.0m $87.0m
Net Other Financing Charges $10.5b $341.0m $138.0m $46.0m
Effect Of Exchange Rate Changes $152.0m ($99.0m) ($54.0m) ($19.0m)
Change In Cash Supplemental As Reported ($546.0m) ($468.0m) $599.0m ($177.0m)
Interest Paid Classified As Financing Activities $732.0m $781.0m $766.0m $895.0m $864.0m $786.0m $848.0m $766.0m $632.0m $679.0m
Income Taxes Paid Refund Classified As Operating Activities $1.6b $1.3b $1.3b $1.5b $1.7b $1.3b ($1.3b) ($1.3b) $1.3b $1.2b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.